perform drive ep growth
forecast strong ep growth ann under-perform
industri sinc result due weak global
macro backdrop stock current trade earn
discount industri ex fin yet ep growth
strong balanc sheet net debt/ebitda
view stock under-valued cautiou implic
subdu macro economi ann earn factor
estim forecast ep growth driven lower raw
materi price cost-out ann benefit even
weak global ip growth persist maintain outperform rate
raw materi price remain low raw materi account ann
cog raw materi price butadien acrylonitril eas
yoy respect declin sinc
similar trend also occur raw materi price includ
cotton polyamid fibr due time lag forecast
ann achiev realis price benefit ann soften
could translat ebit benefit
evid price increas despit weak macro data continu
deterior pmi trend across ann key market particularli europ
remain cautiou ann top-lin perform result
forecast ann miss cc organ growth forecast
organ sale growth howev us distributor
seen margin compress result price increas
manufactur ann suggest ann effect
pass price increas would like see evid ann
factor benefit forecast estim increas
organ revenu growth driven sole price increas ep
rais target price follow ep
upgrad chang
valuat metric
chang previou ep
price month
total return forecast perspect
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price book
return equiti
return asset
return invest cap
net debt ebitda
capital-expenditure sale
capital-expenditure depr
price jul rate outperform target price analyst gretel janu
profit tax
profit tax
unusu item tax
chang work capit
cash non-cash item
movement cash/equival
 asx close
spot exchang rate
strong growth despit weak macro outlook
ann manag guid ep tighten
result previou guidanc rang evid improv
macro environ lower buy-back activ vs ep
estim sit lower end manag guidanc rang
forecast ep vs pcp consensu
forecast group ebit margin increas despit assum organ
growth bottom-end manag guidanc rang raw
materi benefit plu complet transform program improv
margin profil industri healthcar gbu factor
headwind us tariff manag believ pass full tariff
figur ann earn bridg ep
charl martineau pm univers toronto raw materi price continu eas
raw materi account ann cog ann largest raw
materi categori fibr engin yarn combin nitril
natur rubber raw materi repres raw materi mix
figur raw materi cog
chart compani data credit suiss estim
key input nitril includ butadien acrylonitril monitor recent
price movement butadien price vs pcp
averag butadien price declin vs acrylonitril price
lower vs pcp declin averag sinc
cotton polyamid fibr price also eas respect
vs pcp
figur raw materi price
figur benefit earn
chart bloomberg profession servic credit suiss estim
figur acrylonitril price vs pcp
chart bloomberg profession servic credit suiss estim
chart bloomberg profession servic credit suiss estim
estim ebit benefit
base assum month lag price impact cog ann
unlik significantli benefit lower butadiene/acrylonitril cotton price
forecast ann achiev realiz price benefit estim
weight realiz price benefit benefit reduc
estim could creat ebit benefit ann
weaker demand outlook price increas come
despit numer cost benefit ann remain cautiou outlook
demand level organ volum growth ann achiev short term
gener weaker pmi trend across ann key market sinc
begin europ enter contract us experienc deterior
trend expansionari activ data develop countri also
weak contract occur russia china deterior brazil figur
note recent pmi data weight ann geograph exposur impli
expect reduct level ip growth figur
figur weaker pmi data
market pmi varianc
figur peak
chart bloomberg profession servic credit suiss estim
implic ann
ann revenu exposur emea saw
sale russia middl east africa brazil
emea ann miss organ growth target achiev cc growth
impact industri gbu slowdown due eu deceler particularli
auto sector select em weak pmi data end june
suggest improv
histor organ growth ann industri gbu follow weight ip growth
key region figur ip growth explain variat organ
revenu growth figur howev recent year seen correl
industri revenu weight ip growth break symptomat
intern issu affect growth
weight basi revenu contribut pmi data indic weaker
activ given pmi data histor provid reason lead indic
industri product ip growth note reason yet precis relationship
ann industri focus gbu ip recent trend highlight scope slower
industri organ growth
figur explain varianc growth
chart compani data bloomberg profession servic credit suiss estim
also monitor trend daili sale growth data grainger
wholesal industri suppli north america ann featur within product
rang line weaker pmi/ip data distributor saw weaker daili sale growth
outperform peer growth weaker
seen grainger report weaker sale growth
msc industri report weaker gross margin distributor
comment continu product inflat suggest manufactur ann
success pass price increas ahead tariff increas
commentari distributor includ
grainger demand environ soften throughout year growth
us slow stabl noth suggest go
significantli weaken level grainger expect market growth
previous grainger expect grow ahead
market
deceler bear full impact escal product cost
still reflect growth
continu
fasten overal activ end market slow quarter panic
sentiment becom cautiou abl off-set product cost
inflat expect coupl percentag point inflat
chart compani data credit suiss estim
ann achiev organ sale growth target
organ growth industri growth healthcar given seen
signific improv industri market condit see downsid risk ann
achiev target rang forecast ann miss target
achiev cc organ sale growth growth predomin come
healthcar divis
chart compani data credit suiss estim
potenti upsid price increas
prefer conserv stage factor price increas
get evid ann success achiev note upsid
forecast estim increas organ revenu growth driven price
volum increas ep forecast
review key activ trend made minor chang
assumpt result earn upgrad adjust includ
updat currenc assumpt base credit suiss in-hous forecast
updat assumpt buy-back given slower rate complet
vs previou forecast
higher organ sale growth forecast middl ann guidanc rang
medium term
retain outperform rate increas dcf-deriv tp target
price stock trade earn
averag discount xji ex-fin view stock
figur pe averag
figur discount market
ann pe rel industri ex financi
chart bloomberg profession servic credit suiss estim
figur healthcar revenu
figur industri ebit
figur cog opex
figur ebit step
figur ep grow
figur dp
chart compani data credit suiss estim
new total return forecast perspect chart help visual credit suiss consensu view compani return within
context forecast risk histor trade pattern
volatil calcul annualis standard deviat weekli total return seri past month illustr variabl
stock return word risk way think one would rather take forecast return stock volatil
stock volatil shade area show one standard deviat rang base past month volatil statist
term make number brave assumpt probabl share price end insid rang month
hi-lo maximum minimum daili close price past week often handi know price momentum especi
stock trade close high low stock trade close peak momentum stock
consensu consensu suppli thomson reuter survey sell side research analyst collect dozen data
point ep dp sale target price roe mean averag target return shade area around mean
repres rang estim lowest highest estim aid visualis number import factor rang
analyst estim credit suiss estim stock sit rel consensu share price rel consensu
mean consensu rang target
return calcul capit gain plu forecast dividend yield net next month cs tgt use credit suiss
target price credit suiss forecast forward dividend gross frank consensu mean rang use
consensu target price consensu dividend forecast month forward
compani mention price
